Prot #1315.1: A Phase I, Open, Cohort Dose Escalation Trial with BI 836858 in Patients with Refractory or Relapsed Acute Myeloid Leukemia

Project: Research project

Project Details

StatusFinished
Effective start/end date10/12/1210/12/18

Funding

  • Boehringer Ingelheim Pharmaceuticals, Inc. (Prot #1315.1)